A Makriyannis Selected Research

A Makriyannis Research Topics

Disease

5	Nausea 11/2010 - 05/2001
4	Inflammation (Inflammations) 12/2018 - 01/2003
4	Pain (Aches) 05/2015 - 01/2003
3	Hyperalgesia 11/2007 - 01/2003
2	Fibrosis (Cirrhosis) 12/2018 - 07/2001
2	Hypothermia 05/2015 - 01/2003
2	Vomiting 09/2010 - 05/2001
2	Hypersensitivity (Allergy) 11/2007 - 01/2007
2	Catalepsy 11/2007 - 01/2003
1	Diabetic Nephropathies (Diabetic Nephropathy) 12/2018
1	Albuminuria 12/2018
1	Gliosis 10/2015
1	Acquired Immunodeficiency Syndrome (AIDS) 10/2015
1	Breast Neoplasms (Breast Cancer) 10/2013
1	Body Weight (Weight, Body) 10/2010
1	Obesity 10/2010
1	Weight Gain 11/2008
1	Ataxia (Dyssynergia) 07/2005
1	Astrocytoma (Pilocytic Astrocytoma) 06/2004
1	Cardiac Arrhythmias (Arrythmia) 05/2002
1	Ischemia 02/2002
1	Coronary Occlusion 02/2002
1	Liver Cirrhosis (Hepatic Cirrhosis) 07/2001
1	Hypotension (Low Blood Pressure) 07/2001
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 07/2001
1	Neoplasms (Cancer) 05/2001
1	Neuromuscular Diseases (Neuromuscular Disease) 02/2001
1	Muscle Spasticity (Spastic) 02/2001
1	Multiple Sclerosis 02/2001

Drug/Important Bio-Agent (IBA)

11	CannabinoidsIBA 12/2018 - 02/2002
5	anandamide (arachidonylethanolamide)IBA 06/2004 - 02/2001
4	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 12/2018 - 07/2001
4	RimonabantIBA 11/2010 - 07/2001
3	EndocannabinoidsIBA 12/2018 - 02/2001
3	AM6545IBA 12/2018 - 09/2010
3	AM 251 (AM251)IBA 09/2010 - 07/2005
3	Cannabinoid Receptor AgonistsIBA 11/2007 - 05/2001
3	AM 1241IBA 01/2007 - 01/2003
3	CarrageenanIBA 01/2007 - 01/2003
2	AntiemeticsIBA 07/2005 - 05/2001
2	methanandamideIBA 05/2002 - 02/2002
1	nephrinIBA 12/2018
1	NPHS2 proteinIBA 12/2018
1	AlbuminsIBA 12/2018
1	Perindopril FDA LinkGeneric 12/2018
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2018
1	CreatinineIBA 12/2018
1	Streptozocin (Streptozotocin)FDA Link 12/2018
1	Dinoprostone (PGE2)FDA Link 10/2015
1	HIV Envelope Protein gp120IBA 10/2015
1	LigandsIBA 05/2015
1	AntioxidantsIBA 10/2013
1	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 10/2013
1	cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA 10/2013
1	Heme Oxygenase-1IBA 10/2013
1	N- (3- (4- chlorophenyl)- 2- (3- cyanophenyl)- 1- methylpropyl)- 2- methyl- 2- ((5- (trifluoromethyl)pyridin- 2- yl)oxy)propanamideIBA 11/2010
1	Cannabinoid Receptor AntagonistsIBA 10/2010
1	Lithium ChlorideIBA 09/2010
1	AM 6527IBA 09/2010
1	SolutionsIBA 09/2010
1	AM4113IBA 11/2008
1	Vincristine (Oncovin)FDA LinkGeneric 11/2007
1	pyrazoleIBA 01/2007
1	SR 144528IBA 01/2007
1	AM1172IBA 06/2004
1	Proteins (Proteins, Gene)FDA Link 01/2003
1	EnzymesIBA 02/2002
1	Nitric Oxide Synthase (NO Synthase)IBA 02/2002
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 02/2002
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 02/2002
1	3'-azido-3'-deoxythymidine 5'- (3- (1- O- hexadecyl- 2- O- methylglycerol)phosphate)IBA 05/2001
1	Opioid Analgesics (Opioids)IBA 05/2001
1	Naloxone (Narcan)FDA LinkGeneric 05/2001
1	Morphine (MS Contin)FDA LinkGeneric 05/2001
1	Glycerol (Glycerine)FDA LinkGeneric 02/2001
1	palmidrolIBA 02/2001

Therapy/Procedure

2	Therapeutics 12/2018 - 02/2001
1	Analgesia 05/2015
1	Injections 11/2007
1	Transcutaneous Electric Nerve Stimulation (TENS) 12/2004
1	Radiotherapy 05/2001
1	Drug Therapy (Chemotherapy) 05/2001